WallStreetZenWallStreetZen

NASDAQ: RGC
Regencell Bioscience Holdings Ltd Stock

$10.39-0.04 (-0.38%)
Updated Dec 8, 2023
RGC Price
$10.39
Fair Value Price
N/A
Market Cap
$135.14M
52 Week Low
$10.13
52 Week High
$32.89
P/E
-23.08x
P/B
11.23x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$5.87M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.05
Operating Cash Flow
-$5M
Beta
0.64
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RGC Overview

Regencell Bioscience Holdings Limited is a bioscience company developing traditional Chinese medicines to treat neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. Regencell Bioscience incorporated in 2014 and is headquartered in Hong Kong.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RGC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RGC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RGC is poor value based on its book value relative to its share price (11.23x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.05x)
P/B vs Industry Valuation
RGC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RGC due diligence checks available for Premium users.

Be the first to know about important RGC news, forecast changes, insider trades & much more!

RGC News

Valuation

RGC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-23.08x
Industry
9.46x
Market
31.32x

RGC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
11.23x
Industry
2.05x
RGC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RGC's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
RGC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$12.6M
Liabilities
$632.3k
Debt to equity
0.05
RGC's short-term assets ($11.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RGC's short-term assets ($11.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RGC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
RGC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RGC vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
RGC$135.14M-0.38%-23.08x11.23x
OPTN$138.71M-1.20%-3.25x-1.79x
AQST$140.21M-2.33%-10.50x-1.36x
EBS$129.00M+2.89%-0.21x0.13x
TKNO$120.76M-4.66%-2.16x1.21x

Regencell Bioscience Holdings Stock FAQ

What is Regencell Bioscience Holdings's quote symbol?

(NASDAQ: RGC) Regencell Bioscience Holdings trades on the NASDAQ under the ticker symbol RGC. Regencell Bioscience Holdings stock quotes can also be displayed as NASDAQ: RGC.

If you're new to stock investing, here's how to buy Regencell Bioscience Holdings stock.

What is the 52 week high and low for Regencell Bioscience Holdings (NASDAQ: RGC)?

(NASDAQ: RGC) Regencell Bioscience Holdings's 52-week high was $32.89, and its 52-week low was $10.13. It is currently -68.43% from its 52-week high and 2.52% from its 52-week low.

How much is Regencell Bioscience Holdings stock worth today?

(NASDAQ: RGC) Regencell Bioscience Holdings currently has 13,012,866 outstanding shares. With Regencell Bioscience Holdings stock trading at $10.39 per share, the total value of Regencell Bioscience Holdings stock (market capitalization) is $135.14M.

Regencell Bioscience Holdings stock was originally listed at a price of $9.56 in Jul 19, 2021. If you had invested in Regencell Bioscience Holdings stock at $9.56, your return over the last 2 years would have been 8.63%, for an annualized return of 4.23% (not including any dividends or dividend reinvestments).

How much is Regencell Bioscience Holdings's stock price per share?

(NASDAQ: RGC) Regencell Bioscience Holdings stock price per share is $10.39 today (as of Dec 8, 2023).

What is Regencell Bioscience Holdings's Market Cap?

(NASDAQ: RGC) Regencell Bioscience Holdings's market cap is $135.14M, as of Dec 11, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Regencell Bioscience Holdings's market cap is calculated by multiplying RGC's current stock price of $10.39 by RGC's total outstanding shares of 13,012,866.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.